International Conference on

Metabolomics & Systems Biology

Scientific Program

Keynote Session:

Meetings International -  Conference Keynote Speaker Luis Lightbourn-Rojas photo

Luis Lightbourn-Rojas

Director, Instituto de Investigacion Lightbourn, Mexico

Title: Biosafety assessment of phiC120, a new bacteriophage to control multidrug-resistant Shiga toxin-producing Escherichia coli (STEC) strains, based on genome sequence analysis

Biography:

Luis Lightbourn, president of the Instituto de Investigacion Lightbourn located at Mexico, he is an expert in microbial biotechnology, food safety, genomics, cell biology and has over 30 years of experience in biochemistry and molecular biology. Throughout his research career, he has focused on an application the metagenomic approach to food pathogen detection utilizing NGS as an analytical tool. He has made a major contribution to understanding the molecular microbial association-microbial interactions. Doctor Lightbourn has a range of expertise that has attracted invitations to contribute to a wide range of activities, including assessment of research strategy, industry consultation, and government advice. 

Abstract:

Statement of the Problem: Escherichia coli and several Salmonella serotypes are worldwide zoonotic pathogens with an enormous epidemiological, and economic impact as one of the leading causes of foodborne illness. The problem is exacerbated by the propensity of these pathogens to develop resistance to antibiotics that were once commonly used to treat them. The emergence of multidrug-resistant (MDRs) bacteria pathogens has sparked renewed interest in bacteriophages as a means of sanitation and biological control in the food processing. Therefore, the aim of this study was to isolate and characterize a lytic bacteriophage capable of infecting specific E. coli and Salmonella strains.  

Methodology & Theoretical Orientation: Phage was isolated from environmental samples using E. coli O157 strain as hosts. To develop an effective antimicrobial agent, bacteriophage called phiC120 was isolated from environmental samples using E. coli O157 strain as hosts and its genome was sequenced because of its ability to lyse the multidrug-resistant strains according to the host range. Moreover, the phage structure was investigated for transmission electron microscopy.

Findings: The bacteriophage has a broad host range of activity against multidrug-resistant E. coli and Salmonella strains. phiC120 was classified as a member of the Myoviridae family, but exhibit unusual morphological characteristics, up to now, have not been described for another phage. Analysis revealed that the phage phiC120 genome consists of 186,570 bp, encoding 281 putative ORFs. Our data indicate that phiC120 does not encode any of the genes associated with lysogeny or virulence factors.

Conclusion & Significance: Considering all these characteristics, phiC120 is a promising candidate for therapeutic and biological control of bacterial pathogens. However, further toxicological testing in animals and in vivo trials are needed to ensure the safety of phage used.  

Meetings International -  Conference Keynote Speaker Joel I. Osorio  photo

Joel I. Osorio

President, RegenerAge Clinic, USA

Title: RegenerAge System: Therapeutic effects of combinatorial biologics (mRNA and allogenic MSCs) with a spinal cord stimulation system on a patient with spinal cord section.

Biography:

Dr. Osorio is an innovative businessman with a distinct entrepreneurial mindset concentrated adding value on areas of Biotechnology (mRNA), Reprogramming & Regenerative Medicine for translational use in humans and a variety of clinical applications aimed for both the private and the public health sectors. Dr. Osorio is the Founder, President, and CEO of RegenerAge Clinic and RegenerAge Beauty initiatives for transnational implementations. Vice President and International Clinical Developer for Bioquark, Inc. Executive Vice President: Chairman of the WAMS Americas Division, member of the WAMS Executive Council (WAMS Executive Board), a member of the WAMS Education & Training Board (ETB), a member of the WAMS Editorial Board, an Honorary Member of the Academy Faculty FWAMS, an Honorary Fellow of the Academy & is also a Senior Partner at WAMS, The World Academy of Medical Sciences.

Abstract:

Bioquantine® a mRNA extract from Xenopus laevis frog oocytes (purified from intra- and extra-oocyte liquid phases of electroporated oocytes), showed potential as a treatment for a wide range of conditions in animal models, including Spinal Cord Injury (SCI) and Traumatic Brain Injuries (TBI) among others. The current study observed beneficial changes with Bioquantine® administration in a patient with a severe SCI. Pluripotent stem cells have therapeutic and regenerative potential in clinical situations CNS disorders. One method of reprogramming somatic cells into pluripotent stem cells is to expose them to extracts prepared from Xenopus laevis oocytes. Due to ethical reasons and legal restrictions we selected a No Option patient, deciding to include in our protocol the RestoreSensor SureScan to complete it. Based on the electrical stimulation for rehabilitation and regeneration after spinal cord injury published by Hamid and MacEwan, we designed an improved delivery method for the in-situ application of MSCs and Bioquantine® in combination with the RestoreSensor® SureScan®. To the present day the patient who suffered a complete section of the spinal cord at T12-L1 shows an improvement in sensitivity, strength in striated muscle and smooth muscle connection, 14 months after the first Bioquantine® and MSCs treatment and 9 months after the placement of RestoreSensor® at the level of the lesion, showing an evident improvement on his therapy of physical rehabilitation (legs movement) on crawling forward and backward and standing on his feet for the first time and showing a progressively important functionality on both limbs.

Oral Session 1:

  • Oral Session I: Metabolomics & Mass Spectrometry |Metabolomic Modelling | Edibilomics & Lipidomics | Transcriptomics & Proteomics | Metabolomics in Drug Discovery | Clinical & Precision Medicine Metabolomics
Meetings International -  Conference Keynote Speaker Simone Cristoni photo

Simone Cristoni

CEO, Ion Source & Biotechnologies, Italy

Title: Serum Steroid Ratio Profiles in Prostate Cancer

Biography:

Dr. Simone Cristoni was the founder of ISB - Ion Source & Biotechnologies, a company operating in Bresso (Milano, Italy), whose mission is to provide innovative services and develop customized assays using proprietary mass spectrometry-based technologies. Previously he was a researcher at the University of Milan and Biosearch Italia pharmaceutical company.
 

Abstract:

Serum steroids are crucial molecules altered in prostate cancer (PCa). Mass spectrometry (MS) is currently the elected technology for the analysis of steroids in diverse biological samples. Steroids have complex biological pathways and stoichiometry and it is important to evaluate their quantitative ratio. MS applications to patient hormone profiling could lead to a diagnostic approach. Here, we employed the Surface Activated Chemical Ionization-Electrospray-NIST (SANIST) developed in our laboratories, to obtain quantitative serum steroid ratio relationship profiles with a machine learning the Bayesian model to discriminate patients with PCa. The approach is focused on steroid relationship profiles and disease association. A pilot study on patients affected by PCa, benign prostate hypertrophy (BPH), and control subjects [prostate-specific antigen (PSA) lower than 2.5 ng/mL] was done in order to investigate the classification performance of the SANIST platform. The steroid profiles of 71 serum samples (31 controls, 20 patients with PCa and 20 subjects with benign prostate hyperplasia) were evaluated. The levels of 10 steroids were quantitated on the SANIST platform: Aldosterone, Corticosterone, Cortisol, 11-deoxycortisol, Androstenedione, Testosterone, dehydroepiandrosterone, dehydroepiandrosterone sulfate (DHEAS), 17-OH-Progesterone and Progesterone. We performed both traditional and a machine learning analysis. We show that the machine learning approach based on the steroid relationships developed here was much more accurate than the PSA, DHEAS, and direct absolute value match method in separating the PCa, BPH and control subjects, increasing the sensitivity to 90% and specificity to 84%. This technology, if applied in the future to a larger number of samples will be able to detect the individual enzymatic disequilibrium associated with the steroid ratio and correlate it with the disease. This learning machine approach could be valid in a personalized medicine setting.

 

Meetings International -  Conference Keynote Speaker Gustavo A. Palacios photo

Gustavo A. Palacios

Core Lead, St. Jude Children's Research Hospital, USA

Title: Use of metabolomics to investigate immunity-associated events

Biography:

Dr. Gustavo A. Palacios is working in St. Jude Children's Research Hospital, USA as an experienced scientist with independence and leadership skills in basic & translational research with extensive experience in molecular genetics and analytical approaches to studying cancer and metabolic disorders. 

Abstract:

Immune-mediated responses, like inflammation, are virtually ubiquitous events in most diseases such as infections and cancers. Although there are numerous ways of how scientific questions related to these processes can be addressed, metabolomics has been used rather sporadically to interrogate physiologic and pathologic mechanisms in these contexts. As a result, immunity-associated metabolism and metabolic conditions under infections or in tumor microenvironments remain largely unexplored. On the other hand, the activity of the immune cells during the clearance of infectious pathogens or cancer cells has significant metabolic consequences, leading to the production of cytokines or cytotoxic molecules like reactive oxygen species, which contribute to the elimination of invading pathogens. Metabolomics profiling provides significant insights into the mechanisms of the physiologic immune response and alterations thereof induced by therapeutic interventions. Therefore, we are broadly using metabolomics to address unknown questions about the processes and mechanisms underlying the immune responses under different scenarios. Altogether, with well-established strategies such as cytological phenotypic profiling, genomics, and proteomics, the use of metabolomics will contribute to a more comprehensive knowledge of how the immune and metabolic responses impact immune-mediated processes.

Meetings International -  Conference Keynote Speaker Mohamed M. A. Abd El-Hameed photo

Mohamed M. A. Abd El-Hameed

Faculty of Science, Alexandria University, Egypt

Title: Comparative biosorption study of Hg (II) using raw and chemically activated almond shell

Biography:

Mohamed M. A. Abd El-Hameed is working as a faculty of Science in Alexandria University, Egypt. He is an experienced analytical chemist with solid experience in Liquid chromatography/Mass spectroscopy-based residue analysis (Pesticide residue, Mycotoxins, PCBs, Growth promoters ) in different food commodities. 

Abstract:

This work presents a comparison between the biosorption of Hg (II) by the raw almond shell and activated almond shell. Almond shell based activated carbon has been obtained by physicochemical activation. Batch biosorption results confirmed that activating condition has a strong influence on the final biosorption process. The biosorbent was characterized using scanning electron microscopy and Fourier transform infrared spectroscopy. To optimize the biosorption conditions pH, adsorbent dose, initial concentration, contact time, stirring speed, and temperature on Hg (II) removal were studied. The optimum conditions for maximum Hg (II) were achieved at 20 and 10 min for raw almond shell and activated almond shell, respectively. The equilibrium data were described well by Langmuir, Freundlich, Dubinin–Radushkevich isotherm models and applying a test of model fitness. The best fit of Langmuir and Freundlich models were found for experimental data, which reveal the homogenous surface of the raw almond shell and the heterogeneity of activated almond shell surface. The kinetic data had been divided into either pseudo first order or second order on the basis of the best fit obtained from calculations, confirmed by a test of kinetic validity. An industrial application was examined to improve high biosorption capacity of raw and activated almond shells toward Hg (II).

Meetings International -  Conference Keynote Speaker Baninia Habchi photo

Baninia Habchi

faculty of Medicine, Aix-Marseille University, France

Title: High throughput metabolomics using ultra high resolution detection and chemometric tools to address health monitoring

Biography:

Baninia Habchi is working as a faculty of medicine in Aix-Marseille University, France. 

Abstract:

Concern for public health involves evaluation of population exposure to toxicants. To do this, robust and high-throughput approaches are required to perform analyses of a large number of samples collected from subjects enrolled in cohort studies. The targeted methods enable detection of only predetermined compounds but do not search for new or unknown markers. Global approaches such as metabolomics which aim to reveal metabolic changes due to environmental stress or diseases can detect even those metabolic biomarkers that are unknown. Direct introduction mass spectrometry (DIMS) characterized by a significant reduction in analysis time is more appropriate for large-scale high throughput analyses such as for phenotyping large cohorts. Additionally, its combination with high-resolution mass spectrometry (DI-HRMS) improves the efficiency of the DIMS approach. Nevertheless, DI-HRMS generates complex data containing several thousands of peaks. Therefore, the objective of my work was to develop a rapid, high-throughput workflow, including the development of chemometric tools, in order to highlight the metabolomic perturbations induced by exposure to toxicants. First, DIMS approach was performed on the urine of farmers professionally exposed to two pesticides using an Orbitrap instrument and a new chemometric tool called Independent Component - Discriminant Analysis was developed for supervised analysis of the DIMS data. The developed methodology was then applied to five types of exposure and two analytical approaches DIMS and LC/MS were examined in order to validate the DIMS approach as well as the developed chemometric data analysis tool [3]. Second, DIMS approach was applied to an instrument of higher performances the FT-ICR, to improve the quality of the DIMS data [4]. The procedure was applied to a large number of samples to test the robustness of the approach. All these works demonstrated the feasibility and effectiveness of our high-throughput metabolomic approach for metabolic phenotyping of large populations.

Meetings International -  Conference Keynote Speaker Vishakha Pandey photo

Vishakha Pandey

PhD, G.B.Pant University of Agriculture and Technology, India

Title: Complementary Genomics, Proteomics and Metabolomics Approaches Unravels Complexity Involved in Molecular Pathogenesis of Karnal Bunt Incited by Tilletia indica in Wheat

Biography:

Vishakha Pandey has her expertise in biotic stress and host-pathogen interaction. Her work on Karnal bunt- Tilletia indica as a model system, resulted in the identification of novel pathogenicity factors. She has elucidated the molecular mechanism of Karnal bunt disease pathogenesis. by complementing hi-throughput Genomics, Proteomics and Metabolomics approach. Such integrated omics approaches resulted in the identification of oxalic acid as key pathogenicity factor in Karnal bunt pathogenesis. 

Abstract:

Karnal bunt (KB) is a major disease of wheat, caused by the hemibiotrophic fungus, Tilletia indica. It is regarded as an economically important disease as the pathogen is quarantined in more than 70 countries. Despite its quarantine significance, there is meager information on the molecular mechanisms of pathogenesis employed by this important fungus to cause disease. Moreover, all the methods used to manage the disease have proven futile. To develop an effective disease management strategy, it is essential to unravel the pathogenic mechanisms utilized by T. indica. In order to understand the molecular mechanisms involved in KB pathogenesis, hi-throughput Genomics, Proteomics and Metabolomics approaches were used. Comparative proteomic analysis of the proteins from T. indica isolates varying in their virulence behavior resulted in identification of putative pathogenicity factors (such as oxalic acid and melanin production by malate dehydrogenase, enolase, respectively), proteins that play crucial role in adhesion, invasion and colonization (Glyceraldehyde-3-phosphate dehydrogenase, Fructose-bisphosphate aldolase, Triose phosphate isomerase), penetration (Secretory lipase), degradation of cell wall and antifungal proteins (Glycoside hydrolase family GH45, Aspartate proteases), MAP kinase signaling (Ste7), protection against host-derived reactive oxygen species (Mannitol dehydrogenase, Thioredoxins). Complementation of proteomic analysis with hybrid genome sequence resulted in the identification of homologs of candidate pathogenicity/virulence factors in T. indica. Further, GC- MS-based metabolic profiling validated the role of oxalic acid as a potential virulence factor in T. indica. Unraveling such complexity of molecular pathogenesis would further help in devising novel and effective disease management strategies including the development of resistant plant genotypes through classical plant breeding or genetic engineering, novel biomarkers for pathogen detection and new targets for fungicide development.